Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126472981 | 12647298 | 1 | I | 20160617 | 20160801 | 20160812 | 20160812 | EXP | US-TEVA-682055USA | TEVA | 0.00 | F | Y | 0.00000 | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126472981 | 12647298 | 1 | PS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | U | 78607 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126472981 | 12647298 | 1 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126472981 | 12647298 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126472981 | 12647298 | Abasia | |
| 126472981 | 12647298 | Dizziness | |
| 126472981 | 12647298 | Feeding disorder | |
| 126472981 | 12647298 | Feeling abnormal | |
| 126472981 | 12647298 | Hyperhidrosis | |
| 126472981 | 12647298 | Nausea | |
| 126472981 | 12647298 | Presyncope | |
| 126472981 | 12647298 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126472981 | 12647298 | 1 | 20160617 | 0 |